Low-flow ECCO2R conjoined with renal replacement therapy platform to manage pulmonary vascular dysfunction with refractory hypercapnia in ARDS

Low-flow ECCO2R conjoined with renal replacement therapy platform to manage pulmonary vascular dysfunction with refractory hypercapnia in ARDS

Background: Hypercapnia worsens lung vascular dysfunction during acute respiratory distress syndrome (ARDS). We tested whether an extracorporeal carbon dioxide removal (ECCO2R) device based on a renal replacement therapy platform (Prismalung®) may reduce PaCO2 and alleviate lung vascular dysfunction...

Full description

Bibliographic Details
Main Authors: Armand Mekontso Dessap, François Bagate, Xavier Repesse, Clarisse Blayau, Muriel Fartoukh, Florence Canoui-Poitrine, Nicolas de Prost, Antoine Vieillard-Baron
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Extracorporeal removal
Renal replacement
Carbon dioxide tension
Pulmonary vascular dysfunction
Acute respiratory distress syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023110863

Similar Items

Similar Items